Boccalini Sara
Department of Health Science, University of Florence, 50134 Florence, Italy.
Vaccines (Basel). 2025 Apr 29;13(5):479. doi: 10.3390/vaccines13050479.
Vaccinations are one of the most impactful public health interventions, saving millions of lives annually and reducing the spread of infectious diseases. Numerous vaccines are expected to become available in the future. Decision-makers will have to thoroughly evaluate them. It is essential to fully comprehend the value of vaccinations to effectively and efficiently guide decisions.
This work aims to highlight the multifaceted benefits of vaccination, extending beyond clinical outcomes to encompass profound economic and societal advantages.
Vaccinations should be considered an investment, not a cost. In comparison to other health expenditures, the vaccine costs can be considered moderate. Vaccinations can also reduce the fiscal burden by avoiding diseases, minimizing lost workdays and absenteeism, lowering disability claims, and increasing workforce productivity. The costs of non-vaccination represent a relevant issue. Vaccination also plays a key role in addressing the global challenge of antimicrobial resistance. Apart from quantifiable economic parameters, vaccines also have intangible benefits reducing pain and avoiding quality of life lost and deaths.
Comprehensive Health Technology Assessments are required to understand the overall value of vaccinations.
疫苗接种是最具影响力的公共卫生干预措施之一,每年挽救数百万人的生命并减少传染病的传播。预计未来会有大量疫苗问世。决策者将不得不对它们进行全面评估。充分理解疫苗接种的价值对于有效且高效地指导决策至关重要。
这项工作旨在突出疫苗接种的多方面益处,其影响不仅限于临床结果,还包括深远的经济和社会优势。
疫苗接种应被视为一种投资,而非成本。与其他医疗支出相比,疫苗成本可被视为适度。疫苗接种还可通过预防疾病、减少工作日损失和旷工、降低残疾索赔以及提高劳动力生产率来减轻财政负担。未接种疫苗的成本是一个相关问题。疫苗接种在应对全球抗菌药物耐药性挑战方面也发挥着关键作用。除了可量化的经济参数外,疫苗还有减少痛苦、避免生活质量下降和死亡等无形益处。
需要进行全面的卫生技术评估以了解疫苗接种的整体价值。